RNA stability enhancers for durable base-modified mRNA therapeutics. #RNAstability #mRNAtherapeutics @natbiotech.nature.com
www.nature.com/articles/s41...

An experimental synthetic #mRNAPlatform could help deliver next-generation #mRNATherapeutics—including #vaccines for #InfectiousDiseases, #cancer, and #AutoimmuneConditions—more quickly and efficiently than current industry standards.

In mRNA therapeutics, even low dsRNA contamination can derail development through unwanted immunogenicity.

Lumit® dsRNA Detection Assay: wash-free, high specificity quantification for fast insight into IVT product quality. Reach out to find out more.

#mRNATherapeutics #DrugDiscovery

🧬 Antiviral Oligonucleotides for Emerging Pathogens
🌍 Redefining the antiviral frontier!
Oligonucleotides bring speed, specificity, and innovation to fight emerging infectious threats.
📅 May 25–26, 2026 | 📍 Rome, Italy
🌐 oligo-nucleotide.com

#mRNAtherapeutics #OligoVaccine #siRNA #DNAbasedDrugs

Building better mRNA for therapeutics. #mRNAtherapeutics #SyntheticBiology #NatureBiotechnology
www.nature.com/articles/s41...

We are looking for a Research Assistant to join the Thaventhiran lab and work on advanced mRNA therapeutics

Fixed term contract (3 years)
£33,002-£35,608
Apply by 17th June

Find out more and apply here: buff.ly/pU1wllN

#vacancy #mRNAtherapeutics

Congratulations to Dr Ritwick Sawarkar and Dr Kadri Seppa who have been awarded €150,000 to develop a novel mRNA therapeutic approach to treat Alzheimer's disease.

Read more about the award: buff.ly/Tfk9Na7

#ERCPoC #mRNAtherapeutics #alzheimersdisease

This review surveys how artificial intelligence is converting the nonlinear design space from empirical iteration into data-efficient, multi-objective optimization.
doi.org/10.59717/j.x...
#artificialintelligence #LipidNanoparticles #mRNATherapeutics

Sciences member, Crafoord Prize recipient) betting heavily on the company's approach offers a fascinating signal.
➡️ More insider buying analysis weekly: bit.ly/3EmrLQA
#InsiderBuying #TheInsidersFund #RNAC #mRNAtherapeutics #CAR-T #NotInvestmentAdvice